Prelude Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | +156.4% | +41.9% | +68.8% | +44.7% | -11.7% | +51.6% | -24.4% | |
| – | +370.0% | +559.9% | +274.9% | +20.1% | +1.9% | -16.7% | -44.2% | |
| – | +339.0% | +553.5% | +322.3% | +24.7% | – | – | – | |
| – | -51.7% | +592.1% | -21.5% | -74.3% | -1,224.4% | – | +573.8% | |
| – | +47.4% | -20.4% | +274.1% | +30.0% | +16.4% | -78.3% | -91.2% | |
| – | +47.4% | -20.4% | +42,380.4% | – | -142.4% | – | -40.7% | |
| – | – | – | – | – | – | – | – | |
| – | +0.0% | +108.1% | -100.0% | – | – | – | -47.3% | |
| – | +65.7% | +728.2% | -33.0% | -99.5% | +16,635.6% | -100.1% | – | |
| – | -26.3% | +5,972.8% | -191.5% | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.